G

GeneSystem Co Ltd
KOSDAQ:363250

Watchlist Manager
GeneSystem Co Ltd
KOSDAQ:363250
Watchlist
Price: 4 080 KRW 0.74% Market Closed
Market Cap: 28.7B KRW

Wall Street
Price Targets

Price Targets Summary
GeneSystem Co Ltd

There are no price targets for GeneSystem Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
GeneSystem Co Ltd Competitors:
Price Targets
CRVO
Diffusion Pharmaceuticals Inc
179% Upside
IMDX
Insight Molecular Diagnostics Inc
12% Upside
FHTX
Foghorn Therapeutics Inc.
114% Upside
XGN
Exagen Inc
158% Upside
VNDA
Vanda Pharmaceuticals Inc
71% Upside
PTCT
PTC Therapeutics Inc
6% Upside
ZNTL
Zentalis Pharmaceuticals Inc
297% Upside
CNTB
Connect Biopharma Holdings Ltd
200% Upside

Revenue
Forecast

Revenue Estimate
GeneSystem Co Ltd

For the last 5 years the compound annual growth rate for GeneSystem Co Ltd's revenue is 1%. The projected CAGR for the next 1 year is 2 911%.

1%
Past Growth
2 911%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
GeneSystem Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
GeneSystem Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GeneSystem Co Ltd's stock price target?
Not Available

GeneSystem Co Ltd doesn't have any price targets made by Wall Street professionals.

What is GeneSystem Co Ltd's Revenue forecast?
Projected CAGR
2 911%

For the last 5 years the compound annual growth rate for GeneSystem Co Ltd's revenue is 1%. The projected CAGR for the next 1 year is 2 911%.

Back to Top